MY107031A - Peptides. - Google Patents
Peptides.Info
- Publication number
- MY107031A MY107031A MYPI91001370A MYPI19911370A MY107031A MY 107031 A MY107031 A MY 107031A MY PI91001370 A MYPI91001370 A MY PI91001370A MY PI19911370 A MYPI19911370 A MY PI19911370A MY 107031 A MY107031 A MY 107031A
- Authority
- MY
- Malaysia
- Prior art keywords
- phe
- pro
- ala
- substituted
- arg
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/086—Bombesin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
THE PRESENT INVENTION PROVIDES A POLYPEPTIDE OF THE FORMULA (I): XX1TRPX2X3X4X5X6X7NH2 WHEREIN IS A GROUP X3 ARG (OR D-ARG)X9X10 AND X8 IS DES NH2PRO, TYRPRO, DES NH2TYRPRO, ADA, PRO, D-PRO OR IS DELETED; X9 IS GLY, ALA, D-ALA OR IS DELETED;X10 IS ASN, PHE, D-PHE,OR PHE OR D-PHE SUBSTITUTED BY ONE OR MORE HALO ATOMS; ORX IS A GROUP A- (CH2)N-CO-IN WHICH A IS A GROUP CONTAINING 1 TO 3 RINGS OF WHICH AT LEAST ONE RING IS AROMATIC, EACH RING SYSTEM BEING OPTIONALLY SUBSTITUTED; AND THE ALKYLENE GROUP IS OPTIONALLY SUBSTUTED BY ONE TO FOUR GROUPS SELECTED FROM AMINO, HYDROXY, C14 ALKOXY AND C14 ALKYL OPTIONALLY SUBSTITUTED BY HALO AND N IS -0 TO 4; OR X IS CYCLOPENTYL CARBONYL SUBSTITUTED BY A GROUP X8 ARG (OR D-ARG) X9X10 AS HEREINBEFORE DEFINED; X1 IS HIS, THIALA OR IS DELETED; X2 IS ALA, D-ALA, CPENC, D-TBUGLY OR PRO; X3 IS VAL OR VAL SUBSTITUTED BY ONE OR MORE HALO ATOMS; X4 IS GLY, ALA, D-ALA, SARCOSINE, PRO, D-PRO OR D-PHE; X5 IS HIS OR THIALA;X6 IS D-PRO,PRO, 2-PYRROLIDINYL-3-HYDROXYPROPIONYL OR D-PRO;X7 IS NLE, LEU, PHE, VAL, MOX, D-PHE, PHE, OR D-PHE SUBSTITUTED BY ONE OR MORE HALO ATOMS OR NAPHTHYLALA OR NAPTHYL D-ALA OR A HYDROPHONIC, SUBTITUTED AROMATIC AMINO ACID OR ARALKYLAMINE OR IS DELETED, AND THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF. THE POLYPEPTIDES POSSESS ANTAGONIST PROPERTIES AGAINST BOMBESIN-LIKE PEPTIDES AND ARE OF VALUE IN THE TREATMENT OF MALIGNANT DISEASE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909016810A GB9016810D0 (en) | 1990-07-31 | 1990-07-31 | Peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY107031A true MY107031A (en) | 1995-08-30 |
Family
ID=10679953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI91001370A MY107031A (en) | 1990-07-31 | 1991-07-30 | Peptides. |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0541654A1 (en) |
| JP (1) | JPH05509100A (en) |
| AU (1) | AU653544B2 (en) |
| CA (1) | CA2088166A1 (en) |
| CZ (1) | CZ8093A3 (en) |
| FI (1) | FI930411A7 (en) |
| GB (1) | GB9016810D0 (en) |
| HU (1) | HUT63178A (en) |
| IE (1) | IE912671A1 (en) |
| IL (1) | IL99009A0 (en) |
| MC (1) | MC2312A1 (en) |
| MY (1) | MY107031A (en) |
| NO (1) | NO930262D0 (en) |
| NZ (1) | NZ239183A (en) |
| PL (1) | PL167322B1 (en) |
| PT (1) | PT98498A (en) |
| SK (1) | SK3893A3 (en) |
| TW (1) | TW234130B (en) |
| WO (1) | WO1992002545A1 (en) |
| ZA (1) | ZA915978B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5723578A (en) * | 1987-09-24 | 1998-03-03 | The Administrators Of Tulane Educational Fund | Peptide analogs of bombesin |
| US5877277A (en) | 1987-09-24 | 1999-03-02 | Biomeasure, Inc. | Octapeptide bombesin analogs |
| US5436137A (en) * | 1992-07-27 | 1995-07-25 | Oregon Regional Primate Research Center | DNA sequence which encodes a peptide capable of promoting acrosome reaction |
| US5620955A (en) * | 1993-06-18 | 1997-04-15 | Peptide Technologies Corporation | Bombesin receptor antagonists and uses thereof |
| JP4954983B2 (en) | 2005-05-18 | 2012-06-20 | ファーマサイエンス・インコーポレイテッド | BIR domain binding compound |
| RU2418807C2 (en) | 2005-10-25 | 2011-05-20 | Аегера Терапьютикс Инк. | Compounds binding iap bir domains |
| MX340870B (en) | 2010-02-12 | 2016-07-27 | Pharmascience Inc | Iap bir domain binding compounds. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU618029B2 (en) * | 1987-11-02 | 1991-12-12 | Imperial Chemical Industries Plc | Polypeptide compounds |
-
1990
- 1990-07-31 GB GB909016810A patent/GB9016810D0/en active Pending
-
1991
- 1991-07-30 PT PT98498A patent/PT98498A/en not_active Application Discontinuation
- 1991-07-30 NZ NZ239183A patent/NZ239183A/en unknown
- 1991-07-30 CZ CS9380A patent/CZ8093A3/en unknown
- 1991-07-30 IL IL99009A patent/IL99009A0/en unknown
- 1991-07-30 CA CA002088166A patent/CA2088166A1/en not_active Abandoned
- 1991-07-30 IE IE267191A patent/IE912671A1/en unknown
- 1991-07-30 JP JP3513218A patent/JPH05509100A/en active Pending
- 1991-07-30 EP EP91914148A patent/EP0541654A1/en not_active Withdrawn
- 1991-07-30 ZA ZA915978A patent/ZA915978B/en unknown
- 1991-07-30 PL PL91297652A patent/PL167322B1/en unknown
- 1991-07-30 WO PCT/GB1991/001289 patent/WO1992002545A1/en not_active Ceased
- 1991-07-30 TW TW080105951A patent/TW234130B/zh active
- 1991-07-30 MC MC912312D patent/MC2312A1/en unknown
- 1991-07-30 AU AU83111/91A patent/AU653544B2/en not_active Ceased
- 1991-07-30 MY MYPI91001370A patent/MY107031A/en unknown
- 1991-07-30 HU HU93239A patent/HUT63178A/en unknown
- 1991-09-30 SK SK3893A patent/SK3893A3/en unknown
-
1993
- 1993-01-26 NO NO930262A patent/NO930262D0/en unknown
- 1993-01-29 FI FI930411A patent/FI930411A7/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0541654A1 (en) | 1993-05-19 |
| MC2312A1 (en) | 1993-09-27 |
| ZA915978B (en) | 1993-04-28 |
| AU8311191A (en) | 1992-03-02 |
| WO1992002545A1 (en) | 1992-02-20 |
| PL167322B1 (en) | 1995-08-31 |
| HU9300239D0 (en) | 1993-04-28 |
| NZ239183A (en) | 1993-07-27 |
| PT98498A (en) | 1992-05-29 |
| GB9016810D0 (en) | 1990-09-12 |
| IE912671A1 (en) | 1992-02-12 |
| IL99009A0 (en) | 1992-07-15 |
| JPH05509100A (en) | 1993-12-16 |
| FI930411A0 (en) | 1993-01-29 |
| NO930262L (en) | 1993-01-26 |
| PL297652A1 (en) | 1992-07-13 |
| CA2088166A1 (en) | 1992-02-01 |
| TW234130B (en) | 1994-11-11 |
| SK3893A3 (en) | 1993-07-07 |
| AU653544B2 (en) | 1994-10-06 |
| FI930411A7 (en) | 1993-01-29 |
| CZ8093A3 (en) | 1994-01-19 |
| NO930262D0 (en) | 1993-01-26 |
| HUT63178A (en) | 1993-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cox | Endogenous opioid peptides: a guide to structures and terminology | |
| Minamino et al. | Neuromedin C: a bombesin-like peptide identified in porcine spinal cord | |
| Folkers et al. | Spantide II, an effective tachykinin antagonist having high potency and negligible neurotoxicity. | |
| Walter et al. | Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia. | |
| PT728146E (en) | CONTOXINE PEPTIDE | |
| ES2063350T3 (en) | NEW PROTEINS WITH AN INHIBITING EFFECT OF TNF AND ITS PRODUCTION. | |
| DK328183A (en) | PROCEDURE FOR THE PREPARATION OF A PEPTIDE INHIBITING THE RELEASE OF GONADOTROPINES FROM THE MILK HONEY | |
| JPH04504406A (en) | therapeutic peptides | |
| IE914140A1 (en) | Nonapeptide bombesin antagonists | |
| EP0352014A3 (en) | Cyclic grf analogs | |
| KR930701483A (en) | GRF (MUF) Analog XI | |
| ES489522A0 (en) | A PROCEDURE FOR THE PREPARATION OF A POLYPEPTIDE | |
| KR910009730A (en) | Peptide | |
| Sandow et al. | Structure-activity relationships in the LH-RH molecule | |
| Folkers et al. | Increased potency of antagonists of the luteinizing hormone releasing hormone which have D-3-Pal in position 6 | |
| ES2180781T3 (en) | NEW LEAGUES OF THE OPIACEO MU RECEIVER: AGONISTS AND ANTAGONISTS. | |
| Boyer et al. | Critical role of an amino acid residue in a T cell determinant is due to its interaction with a neighboring non‐critical residue | |
| AU8302791A (en) | Recombinant gene coding for a protein having an endochitinase activity | |
| JPH07508763A (en) | Antagonist of human gamma interferon | |
| KR930012034A (en) | Bradykinin-antagonists for the treatment of acute pancreatitis | |
| AU622708B2 (en) | Fibroblast growth factor antagonists | |
| Packard | Identification of a synthetic nonapeptide sequence that inhibits motility in culture of a melanoma subclone that possesses a high metastatic potential. | |
| GB1432249A (en) | Peptide enzyme inhibitor | |
| KR19980703438A (en) | Peptides with Growth Promoting Properties | |
| Hlaváček et al. | Insect oostatic activity of GnRH and its fragments |